EVO ICL™ Surgery
The vision correction specialists at Skyline LASIK offer a range of vision correction solutions, allowing us to customize each patient’s experience according to their unique needs, refractive errors, and lifestyle. We are proud to offer our patients from the Colorado Springs, CO area advanced refractive surgery with the EVO ICL lens, an innovative vision correction procedure that may free patients with nearsightedness and astigmatism from the hassle of glasses and contact lenses.FIND OUT IF EVO IS RIGHT FOR YOU!
EVO ICL™ Surgery
The vision correction specialists at Skyline LASIK offer a range of vision correction solutions, allowing us to customize each patient’s experience according to their unique needs, refractive errors, and lifestyle. We are proud to offer our patients from the Colorado Springs, CO area advanced refractive surgery with the EVO ICL lens, an innovative vision correction procedure that may free patients with nearsightedness and astigmatism from the hassle of glasses and contact lenses.
Who is a Candidate for EVO ICL?
EVO ICL may be an excellent option for you, even if you don’t qualify for LASIK or PRK. Ideal candidates for EVO ICL:
- Is between the ages of 21 and 45
- Has moderate to severe nearsightedness (myopia) with or without astigmatism
- Has had a stable vision prescription for at least one year
- Has healthy eyes with no history of eye disease such as glaucoma
EVO ICL Recovery and Results
You won’t need much downtime after your EVO ICL surgery: the majority of our patients go back to work or school the very next day. One of the best things about EVO ICL is how quickly it works: you will notice a significant improvement in your vision nearly immediately!
Frequently Asked Questions About EVO ICL
Is EVO ICL surgery painful?
No. You will be given anesthetic eye drops before your surgical procedure, so you should not feel any pain.
Will other people be able to see the EVO ICL in my eye?
No. Nobody will be able to notice the EVO ICL in your eye, and unlike a contact lens, you will not feel it.
Is EVO ICL safe?
EVO ICL is FDA-approved and is considered to be both safe and highly effective. The best way to ensure optimal vision correction surgery results is to work with an experienced ophthalmologist.
Is the EVO ICL lens permanent?
EVO ICL is designed to provide permanent vision correction in patients who have myopia (nearsightedness) with or without astigmatism. However, one benefit of EVO ICL is that it can be removed if a patient’s needs change, which offers our patients flexibility for the future.
It is important to note that, while EVO ICL can correct a patient’s current vision, it can not prevent changes to the eye that are a part of the natural aging process. Patients may still require reading glasses to help with age-related near vision loss, or presbyopia, which begins to affect everyone in their 40’s.
How much does EVO ICL cost?
The cost of an EVO ICL procedure will depend on your customized treatment plan. Many of our EVO ICL patients find that the investment in their vision is well worthwhile, especially when they see the long-term savings of not paying for glasses and contact lenses. Ask about our payment options for your EVO ICL procedure.
1 Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125. Available: https://pubmed.ncbi.nlm.nih.gov/33577790/. Accessed September 6, 2023.
2 Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53. Available: https://pubmed.ncbi.nlm.nih.gov/35645557/. Accessed September 6, 2023.
3 Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215. Available: https://pubmed.ncbi.nlm.nih.gov/27418804/. Accessed September 6, 2023.
4 Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438. Available: https://pubmed.ncbi.nlm.nih.gov/30568421/. Accessed September 6, 2023.
5 Parkhurst GD, Psolka M, Kezirian GM. Phakic Intraocular Lens Implantation in United States Military Warfighters: A Retrospective Analysis of Early Clinical Outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481. Available: https://pubmed.ncbi.nlm.nih.gov/21243974/. Accessed September 6, 2023.
6 Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017;11:1253-1263. Available: https://pubmed.ncbi.nlm.nih.gov/28740361/. Accessed September 6, 2023.